The House easily approved a sweeping biomedical bill Wednesday that would help drug and medical device companies win swifter government approval of their products, boost disease research and drug-abuse spending and revamp federal mental health programs.
The compromise, which envisions spending $6.3 billion over the next decade, was condemned by consumer groups and some Democrats as a present to drugmakers that promised only paltry spending increases for underfunded federal programs.
But their objections were overwhelmed by an alliance among Republicans, many Democrats and the White House for a 996-page measure that bore wins for both parties. The Senate’s expected final approval next week would mark an uncommon episode of cooperation between the GOP-run 114th Congress – which plans to adjourn next week – and President Barack Obama in their dwindling days in office.
Click here to Read the full article : House Passes Controversial Medical Funding ‘Cures’ Bill
Share this entry
- The American Health Council Welcomes Heng Lim, MD to its Board of Physicians January 22, 2018
- The American Health Council Physician Board Welcomes Domenico Calcaterra, MD, PhD, FACS, FCCP, FACC January 19, 2018
- The American Health Council Nursing Board Welcomes Angela Quinn, BA, MCP, MSN, NP-BC January 17, 2018
- The American Health Council Appoints Janiece Fazio, RN, BSN to Nursing Board January 17, 2018
- The AHC Promotes Cervical Health Awareness Month January 16, 2018
- The American Health Council Names Lisa Cavanaugh, PA to Physician Board January 15, 2018